zileuton: Clinical Trials

7 trials of zileuton, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated, 1 recruiting. 7 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 3, Terminated 3, Recruiting 1
Phase 23Completed 2, Terminated 1

Follow zileuton: new trials by email Literature Review of zileuton trials Research Report on zileuton

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Zileuton for Food Allergy
Zileuton extended release - Food Allergies
Phase 1RecruitingAbigail Lang202026-11-032026-11-13
Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia
Zileuton (Zyflo®) Dasatinib (Sprycel®), Dosing with Zileuton/Dasatinib in CML, Daily dosing of Zileuton/Dasatinib - Chronic Myelogenous Leukemia
Phase 1TerminatedUniversity of Massachusetts, Worcester22014-01-012016-09-30
Trial of Zileuton CR in Children and Adults With Sickle Cell Disease
Zileuton - Sickle Cell Disease
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati92010-09-012014-06-18
Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
Zileuton, Celecoxib, laboratory biomarker analysis - Tobacco Use Disorder
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)842010-05-012015-04-02
Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Zileuton - Chronic Myelogenous Leukemia
Phase 1TerminatedUniversity of Massachusetts, Worcester22010-01-012015-05-27
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis
Phase 1 / Phase 2TerminatedNational Human Genome Research Institute (NHGRI)32007-04-012013-08-02
Safety Study of Zileuton Injection in Patients With Asthma
Zileuton injection - Asthma
Phase 1 / Phase 2CompletedCritical Therapeutics602006-01-012007-09-26

Conditions studied

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Albinism (1)  ·  Albinism, Oculocutaneous (1)  ·  Anaphylaxis (1)  ·  Anemia, Sickle Cell (1)  ·  Asthma (1)  ·  Asthma, Exercise-Induced (1)  ·  Food Hypersensitivity (1)  ·  Hermanski-Pudlak Syndrome (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Lung Diseases (1)  ·  Metabolic Diseases (1)  ·  Myeloproliferative Disorders (1)  ·  Platelet Storage Pool Deficiency (1)

Sponsors

University of Massachusetts, Worcester (2)  ·  Abigail Lang (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Critical Therapeutics (1)  ·  National Cancer Institute (NCI) (1)  ·  National Human Genome Research Institute (NHGRI) (1)

Countries

United States (7)

Top investigators

Jan Cerny, MD, PhD (2)  ·  Dana Hilt, MD (1)  ·  Powel Brown, MD (1)  ·  Punam Malik, MD (1)  ·  Thomas Markello, M.D. (1)

Results publications

PMID 17151364, PMID 19503090

NIH funding

N01CN35159 (1)